ANO-31905

· Anova Innovation Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANO-31905, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer [Phase 1, Phase 2]

See pricing